METHYCOBAL

This brand name is authorized in Cyprus, Hong Kong SAR China, Japan, Singapore.

Active ingredients

The drug METHYCOBAL contains one active pharmaceutical ingredient (API):

1	Mecobalamin UNII BR1SN1JS2W - METHYLCOBALAMIN
	Methylcobalamin is a cobalamin, a form of vitamin B12. Mecobalamin is a kind of endogenous coenzyme B12. Mecobalamin plays an important role in transmethylation as a coenzyme of methionine synthetase in the synthesis of methionine from homocysteine. Mecobalamin promotes axonal transport and axonal regeneration. Mecobalamin promotes myelination (phospholipid synthesis). Methylcobalamin is used in the treatment of peripheral neuropathy, diabetic neuropathy, and as a preliminary treatment for amyotrophic lateral sclerosis.
	Read more about Mecobalamin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
METHYCOBAL Solution for injection	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
METHYCOBAL Tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03BA05	Mecobalamin	B Blood and blood forming organs → B03 Antianemic preparations → B03B Vitamin B12 and folic acid → B03BA Vitamin B12 (cyanocobalamin and analogues)
Discover more medicines within B03BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	30872, 35777, 64652
JP	医薬品医療機器総合機構	3136004C1038, 3136004F1050, 3136004F2138, 3136403A1140
SG	Health Sciences Authority	06291P, 06349P